4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-016722
CHIEF OPERATING OFFICER sold 70,867 shares at an average $30.48 ($2,160,035)
- CHIEF OPERATING OFFICER acquired 70,867 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tessari Eben CHIEF OPERATING OFFICER | 2025-06-09 | Option exercise 10b5-1 | +10,319 | $10.36 | $106,905 | 82,682 | D |
| Tessari Eben CHIEF OPERATING OFFICER | 2025-06-09 | Sale 10b5-1 | −10,319 | $30.38 | $313,491 | 72,363 | D |
| Tessari Eben CHIEF OPERATING OFFICER | 2025-06-10 | Option exercise 10b5-1 | +15,506 | $10.36 | $160,642 | 87,869 | D |
| Tessari Eben CHIEF OPERATING OFFICER | 2025-06-10 | Sale 10b5-1 | −15,506 | $30.46 | $472,313 | 72,363 | D |
| Tessari Eben CHIEF OPERATING OFFICER | 2025-06-11 | Option exercise 10b5-1 | +45,042 | $10.36 | $466,635 | 117,405 | D |
| Tessari Eben CHIEF OPERATING OFFICER | 2025-06-11 | Sale 10b5-1 | −45,042 | $30.51 | $1,374,231 | 72,363 | D |
| Derivatives | |||||||
| Tessari Eben CHIEF OPERATING OFFICER | 2025-06-09 | Option exercise · Share Option 10b5-1 | −10,319 | 99,476 | D | ||
| Tessari Eben CHIEF OPERATING OFFICER | 2025-06-10 | Option exercise · Share Option 10b5-1 | −15,506 | 83,970 | D | ||
| Tessari Eben CHIEF OPERATING OFFICER | 2025-06-11 | Option exercise · Share Option 10b5-1 | −45,042 | 38,928 | D | ||
| Open-market sales · 70,867 sh · avg $30.48 · $2,160,035 | |||||||
Loading xslF345X05/form4-06112025_090628.xml…